A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

Abroad (travel likely)
RecruitingPHASE2

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Immunodeficiency · Hematopoietic Stem Cell Transplantation

Locations
  • National Institutes of Health Clinical Center, Bethesda, Maryland, United States